Trial Profile
DMT210 Topical Gel in the Treatment of Mild to Moderate Atopic Dermatitis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 Apr 2018
Price :
$35
*
At a glance
- Drugs DMT 200 (Primary)
- Indications Atopic dermatitis
- Focus Therapeutic Use
- Sponsors Dermata Therapeutics
- 17 Apr 2018 Status changed from active, no longer recruiting to completed.
- 07 Jun 2017 Planned End Date changed from 1 Mar 2017 to 1 Aug 2017.
- 07 Jun 2017 Planned primary completion date changed from 1 Mar 2017 to 1 Aug 2017.